Assessment of Left Atrial Deformation and
Dyssynchrony by Three-dimensional
Speckle Tracking Imaging: Comparative
Studies in Healthy Subjects and Patients
with Atrial Fibrillation
Atsushi Mochizuki, MD*; Satoshi Yuda, MD, PhD*
,**; Yukiko
Oi, MT
***, Mina Kawamukai, MD*; Junichi Nishida, MD*;
Atsuko Muranaka, MD, PhD*; Hidemichi Kouzu*, MD, PhD;
Nobuaki Kokubu, MD, PhD*; Shinya Shimoshige, MD*;
Akiyoshi Hashimoto, MD, PhD*; Kazufumi Tsuchihashi, MD,
PhD*; Naoki Watanabe, MD, PhD
**; Tetsuji Miura, MD, PhD*
Second Department of Internal Medicine*,
Department of Clinical Laboratory Medicine
**,
Sapporo Medical University School of Medicine,
Sapporo, Japan
Division of Laboratory Diagnosis
***,
Disclosure
All the authors have no conflict of interest
to disclose in this study.
Background 1
Left atrial (LA) strain which is measured
by strain rate imaging and
two-dimensional speckle tracking (2DS) is
impaired in patients with atrial fibrillation
(AF).
Inaba Y, et al. J Am Soc Echocardiogr 2005; 18: 729-36
Tsai WC, et al. Echocardiograpy 2009; 26: 1188-94
2DS is enable to quantify LA synchrony,
and LA asynchrony can predict AF
recurrence post electrical cardioversion.
A newly developed 3-dimensional (3D)
speckle tracking echocardiography (3DS)
can quantify 3D left ventricular (LV) strain
and LV dyssynchrony.
Saito K, et al. J Am Soc Echocardiogr 2009; 22: 1025-30
Tanaka H, et al. Am J Cardiol 2010; 105: 235-42
However, whether 3DS is applicable for
evaluation of LA functions remains
unclear. Furthermore, alterations in 3D LA
morphology and function in patients with
AF have not been characterized.
Objective
We examined whether LA strains
and synchrony are assessable by
3DS and how the 3DS parameters
are modified by AF.
Study Population
Healthy subjects: n=77
age 32
±
14 years, 48 males, 29 females
Patients with Non-valvular AF: n=30
・
Paroxysmal AF (PAF): n=20
age 61
±
6 years, 14 males, 6 females
・
Permanent AF: n=10
age 62
±
8 years, 8 males, 2 females
Control group and PAF patients were in sinus
rhythm at the time of echocardiographic
examination.
Exclusion criterion was presence of
regional or global LV systolic dysfunction
(ejection fraction [EF] <55%).
Conventional Echocardiographic Examination
Two-dimentional echocardiography 1. LA diameter (LAD, mm)
2. EF (%) (by biplane modified Simpson’s method) 3. LA volume index (LAVI, ml/m2): biplane Simpson’s
method and normalized for body surface area 4. LV mass index (LVMI, g/m2)
Pulsed-wave Doppler echocardiography Transmitral flow velocities
5. peak velocity during early diastole (E, cm/s) 6. peak velocity during late diastole (A, cm/s) 7. E/A
Tissue Doppler imaging
Myocardial velocities at the medial mitral annulus 8. peak velocity during early diastole (e’, cm/s) 9. peak velocity during late diastole (a’, cm/s) 10. E/e’
Artida (Toshiba Medical Systems, Tokyo, Japan) equipped with a PST-25SBT transducer was used in the present study.
Measurement of LA Strain by 2DS
The LA endocardial border was manually traced in both apical four- and two-chamber views and the software automatically tracks the contours on the subsequent frames.
Peak longitudinal LA strain during systole (2D-LSs) was calculated by averaging the value of the 6 segments.
[Representative measurements of 2D-LSs]
Measurement of LA Strain by 3DS
With 3D echocardiographic datasets, the software detects the LA endocardium using a semi-automated contour-tracing
algorithm and divides the LA into 16 segments.
LA longitudinal (LS), circumferential (CS) and area (AS) strains for each segment and maximal LA volume (3D-LAV) are
automatically calculated.
Peak LS, CS and AS are measured in systole (LSs, CSs, ASs)
and late diastole (LSa, CSa, ASa).
ASs 65%
ASa 25% Control
Assessments of LA Synchrony by 3DS
To quantify LA synchrony, standard deviations (SD) of times to peaks of regional LSs, CSs, ASs, LSa, CSa and ASa were calculated.
Each parameter of LA synchrony was corrected by the R-R’ interval.
[Representative 16 Segmental LA Area Strain Curves]
Control PAF
Feasibility and Time needed for
Analysis
2DS
3DS
p
value
Healthy subjects
77/76 (99%)
75/77 (97%)
NS
AF patients
30/30 (100%) 30/30 (100%)
NS
Time for analysis, min
4.0
±
2.3
3.3
±
1.9
<0.05
The feasibility of 3DS was comparable with
that of 2DS for LA longitudinal strain.
The mean time needed for analysis for 3DS
was 18%
shorter
than for 2DS (p<0.05).
Inter
observer Variability
-20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 20 40 60 80 100 120 2D-LSs (CV=18.0%) mean dif = -3.1 SD = 5.3 LSs (CV=8.5%) mean dif = -0.2 SD = 3.1 +1.96SD -1.96SD +1.96SD -1.96SD mean dif = -0.4 SD = 3.5 +1.96SD -1.96SD ASs (CV=8.6%) +1.96SD -1.96SD obs er ver 1 – obs er ver 2 ( %) obs er ver 1 – obs er ver 2 ( %) obser ver 1 – obser ver 2 ( %) obs er ver 1 – obs er ver 2 ( %)mean 2D-LSs of observer 1 and 2 (%)
mean CSs of observer 1 and 2 (%) mean ASs of observer 1 and 2 (%) mean LSs of observer 1 and 2 (%)
CSs (CV=9.8%)
60
mean dif = -0.7 SD = 6.8
Intra
observer Variability
-20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 10 20 30 40 50 -20 -15 -10 -5 0 5 10 15 20 0 20 40 60 80 100 120 2D-LSs (CV=12.1%) mean dif = -0.9 SD = 5.4 LSs (CV=10.3%) mean dif = -0.7 SD = 3.3 +1.96SD -1.96SD +1.96SD -1.96SD mean dif = -2.0 SD = 4.3 +1.96SD -1.96SD ASs (CV=8.7%) +1.96SD -1.96SD 1s t - 2nd measur ement (%) 1s t - 2nd measur ement (%) 1st - 2nd measur ement (%) 1s t - 2nd measur ement (%)mean 2D-LSs of 1st & 2nd measurement (%)
CSs (CV=11.6%)
60
mean dif = -3.2 SD = 7.5
CV: Coefficient of Variation
mean LSs of 1st & 2nd measurement (%)
mean ASs of 1st & 2nd measurement (%) mean CSs of 1st & 2nd measurement (%)
Clinical Characteristics in
Age-matched
Healthy Controls and Patients with AF
Control
(
n=15
)
(n=20)
PAF
Permanent AF
(n=10)
Age, years
57.9
±
5.4
61.2
±
5.7
62.4
±
7.6
Male
12 (80%)
14 (70%)
8 (80%)
Systolic BP, mmHg
118
±
13
113
±
14
122
±
16
Diastolic BP, mmHg
79
±
9
74
±
8
79
±
16
Heart rate, beats/min
65
±
10
61
±
15
68
±
16
Hypertension
0
4 (20%) 5 (50%)
Diabetes mellitus
0
3 (15%)
5 (50%)
Calcium antagonist
0
8 (40%)
5 (50%)
ACE-inhibitors or ARBs
0
2 (10%)
3 (30%)
Beta-blockers
0
12 (60%)
2 (20%)
Duration of AF, years
-
7.4
±
6.7
11.6
±
8.2
Echocardiographic Parameters
Control
(
n=15
)
(n=20)
PAF
Permanent AF
(n=10)
2D-LAVI, ml/m
227
±
8
36
±
15*
51
±
15*
,**
3D-LAVI, ml/m
226
±
7
35
±
14*
53
±
16*
,**
LVMI, g/m
2118
±
23
143
±
29*
137
±
35
LVEF, %
69
±
5
68
±
5
67
±
5
E, cm/s
60
±
12
68
±
1.7
88
±
18*
,**
A, cm/s
62
±
11
61
±
24
-
DcT of E, ms
189
±
34
187
±
61
161
±
35
e’, cm/s
10.1
±
1.9
9.3
±
2.3
10.6
±
2.9
a’, cm/s
11.5
±
1.8
8.5
±
2.6*
-
E/e’
6.1
±
1.4
7.6
±
2.2
8.6
±
2.4*
*p<0.05 vs control, **p<0.05 vs PAFPeak LA Strain during
Systole
- LA Reservoir Function -
*p<0.05 vs control, **p<0.05 vs PAF 0 10 20 30 40 50 60 70 80 902D-LSs
LSs
CSs
ASs
Age-matched Control
PAF
Permanent AF
* *,** * *,** * *,** * *,** (%)
*p<0.05 vs control, **p<0.05 vs PAF 0 10 20 30 40 50
LSa
CSa
ASa
Age-matched Control
PAF
*
*
*
Peak LA Strain during
Late Diastole
- LA Booster Pump Function -
*p<0.05 vs control
LA Synchrony during
Systole
- Synchrony in Reservoir Phase -
0 5 10 15 20 25 30
SD-LSs
SD-CSs
SD-ASs
Age-matched Control
PAF
Permanent AF
* * * * (%) * * (%)
0 10 20 30 40
SD-LSa
SD-CSa
SD-ASa
Age-matched Control
PAF
* *
(%)
LA Synchrony during
Late Diastole
- Synchrony in Booster Phase -
*p<0.05 vs control
Control Permanent AF ASs 80% ASa 32% SD-ASs 3.5% SD-ASa 8.2% ASs 49% ASa 13% SD-ASs 4.6% SD-ASa 9.0% ASs 13% ASa N/A SD-ASs 11.2%
SD-ASa N/A PAF
Independent Predictors of
PAF Patients
- Multivariate Logistic Regression Analysis -
Model 1
Model 2
Odds
ratio 95% CI
p
value
Odds
ratio 95% CI
p
value
2D-LSs
0.71
0.51-0.990.045
CSs
0.77
0.59-0.990.043
ASs
0.90
0.83-0.970.011
SD of ASa
1.15
1.01-1.310.039
Model 1: age, LSs, LSa, CSs, CSa, 2D-LSs, lateral a’, 2D-LAVI, LVMI,
SD of LSs, SD of LSa, SD of CS, SD of CSa
Model 2: age, ASs, ASa, 2D-LSs, lateral a’, 2D-LAVI, LVMI, SD of ASs,
Sensitivity and Specificity of
Prediction of PAF
- ROC Analysis -
Optimal
Threshold
Sensitivity Specificity
AUC
2D-LSs
<26%
100%
75%
0.85
CSs
<32%
80%
95%
0.88
ASs
<57%
87%
85%
0.89
Summary 1
1. The feasibility of 3DS for assessing LA
function was comparable with that of 2DS for
assessing LA longitudinal strain.
2. Interobserver and intraobserver variabilities
of LA strains in 3DS were relatively small
compared with those of 2DS.
3. Not only longitudinal but also circumferential
and area strains of LA were reduced in both
PAF and permanent AF patients.
4. LA dyssynchrony during systole and late
diastole was significantly larger in patients
with AF than in age-matched controls.
5. 2D-LSs and CSs were significant predictors of
PAF patients in a model using directional LA
strain indices (model 1).
6. In a model using area strain indices (model 2),
ASs and SD of ASa were significant predictors
of PAF patients.
Clinical Implications
1. 3DS may be more suitable for serial and
comprehensive assessment of effects of
interventions (e.g. cardioversion and
pulmonary vein isolation) on LA functions and
also for risk stratification of patients with AF
and/or LV dysfunction.
2. Close examination of relationships between
changes in LA functions, including synchrony,
and development of PAF might provide novel
knowledge for prediction of new-onset AF.
Conclusion
3DS is feasible for measurement of both
LA strain and synchrony with excellent
reproducibility. 3DS shows significant LA
dysfunction and dyssynchrony in both PAF
and permanent AF patients. 3D LA strain
appears to be comparable to the 2D LA
strain for identifying PAF patients.